[Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
[Notices]
[Pages 53385-53386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18917]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Clinical Care Commission

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct a virtual meeting on September 11, 2020. The Commission is 
charged to evaluate and make recommendations to the U.S. Department of 
Health and Human Services (HHS) Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.

DATES: The meeting will take place on September 11, 2020, from 1 p.m. 
to approximately 5:30 p.m. Eastern Daylight time (EDT).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc_sept2020/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: Jennifer Anne Bishop, ScD, MPH, 
Designated Federal Officer, National Clinical Care Commission, U.S. 
Department of Health and Human Services, Office of the Assistant

[[Page 53386]]

Secretary for Health, Office of Disease Prevention and Health 
Promotion, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852. Phone: 
(240) 453-8826. Email: [email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals and entities who 
represent diverse disciplines and views. The Commission will evaluate 
and make recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.
    The eighth meeting will be held virtually, and will consist of 
updates from the Commission's three subcommittees and a discussion of 
public comments and outreach to stakeholder organizations. 
Additionally, the first round of potential ``action plans'' from the 
subcommittee (i.e., recommendations) to be discussed by Commission. The 
final meeting agenda will be available prior to the meeting at https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be an 
opportunity for limited oral comments (each no more than 3 minutes in 
length) at this virtual meeting. Virtual attendees who plan to provide 
oral comments at the Commission meeting during a designated time must 
register prior to the meeting at https://kauffmaninc.adobeconnect.com/nccc_sept2020/event/event_info.html.
    Written comments are welcome throughout the entire development 
process of the Commission's work and may be emailed to [email protected]. 
Written comments should not exceed three pages in length.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by August 27, 2020.
    Authority: The National Clinical Care Commission is required under 
the National Clinical Care Commission Act (Pub. L. 115-80). The 
Commission is governed by provisions of the Federal Advisory Committee 
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: August 24, 2020.
Paul Reed,
Deputy Assistant Secretary for Health, Acting Director, Office of 
Disease Prevention and Health Promotion, Office of the Assistant 
Secretary for Health.
[FR Doc. 2020-18917 Filed 8-27-20; 8:45 am]
BILLING CODE 4150-32-P